Molecular genetic and proteomic analysis of synchronous malignant gliomas

Z. Zhuang, Y. S. Lee, W. Zeng, M. Furuta, T. Valyi-Nagy, M. D. Johnson, C. L. Vnencak-Jones, R. L. Woltjer, R. J. Weil

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Described is a patient with concurrent discrete gliomas: a pleomorphic xanthoastrocytoma with anaplastic features and an anaplastic oligoastrocytoma. The distinct and morphologically dissimilar tumors demonstrated similar genetic abnormalities by loss of heterozygosity and comparative genome hybridization. Clonality and proteomic analyses highlighted an independent origin for the two tumors. Proteomic methods may prove useful in cases where the differential diagnosis and pathogenetic origin of tumors are uncertain, as well as more globally for its ability to provide insight into specific expression of proteins that may serve as unique markers of tumorigenesis or as novel targets of therapy.

Original languageEnglish (US)
Pages (from-to)2316-2319
Number of pages4
JournalNeurology
Volume62
Issue number12
DOIs
StatePublished - Jun 22 2004

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Molecular genetic and proteomic analysis of synchronous malignant gliomas'. Together they form a unique fingerprint.

  • Cite this

    Zhuang, Z., Lee, Y. S., Zeng, W., Furuta, M., Valyi-Nagy, T., Johnson, M. D., Vnencak-Jones, C. L., Woltjer, R. L., & Weil, R. J. (2004). Molecular genetic and proteomic analysis of synchronous malignant gliomas. Neurology, 62(12), 2316-2319. https://doi.org/10.1212/WNL.62.12.2316